- Home
- Labeler Index
- Mylan Specialty L.p.
- 49502-250
- NDC Crossover: 49502-250 Semglee
NDC Crossover 49502-250 Semglee
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Insulin Glargine
Explore similar products and medications to NDC 49502-250 Semglee a human prescription drug with other products crossover matching the same product name (Semglee) or generic name (Insulin Glargine-yfgn), and the same administration route (subcutaneous) or dosage form (injection, solution). This comprehensive list of related drugs for easy comparison is ideal for healthcare professionals & patients seeking alternatives.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
49502-251 | Semglee | Insulin Glargine-yfgn | Injection, Solution | Subcutaneous | Mylan Specialty L.p. | Human Prescription Drug |
49502-393 | Insulin Glargine | Insulin Glargine-yfgn | Injection, Solution | Subcutaneous | Mylan Specialty L.p. | Human Prescription Drug |
49502-394 | Insulin Glargine | Insulin Glargine-yfgn | Injection, Solution | Subcutaneous | Mylan Specialty L.p. | Human Prescription Drug |
83257-011 | Semglee | Insulin Glargine-yfgn | Injection, Solution | Subcutaneous | Biocon Biologics Inc. | Human Prescription Drug |
83257-012 | Semglee | Insulin Glargine-yfgn | Injection, Solution | Subcutaneous | Biocon Biologics Inc. | Human Prescription Drug |
83257-014 | Insulin Glargine | Insulin Glargine-yfgn | Injection, Solution | Subcutaneous | Biocon Biologics Inc. | Human Prescription Drug |
83257-015 | Insulin Glargine | Insulin Glargine-yfgn | Injection, Solution | Subcutaneous | Biocon Biologics Inc. | Human Prescription Drug |